Cardiology

Evinacumab cuts cholesterol levels by half in patients with HoFH

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled ...

Cardiology

Rivaroxaban reduces risk in symptomatic PAD post-intervention

People with symptomatic peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing a procedure to treat blocked arteries in the leg (lower extremity revascularization) had a 15% reduction ...

Cardiology

Mayo Clinic Minute: What's a cardiac stress test?

Your heart provides blood to all parts of your body. In order to determine if it's pumping properly, your health care provider may order a cardiac stress test. It makes the heart pump harder and faster, and can reveal potential ...

Cardiology

AI imaging analysis prognostic in coronary artery disease

(HealthDay)—Reduced myocardial blood flow (MBF) and myocardial perfusion reserve (MPR) are prognostic for patients with coronary artery disease, according to a study published online Feb. 14 in Circulation.

page 40 from 40